Pfizer (PFE) Tops Q1 EPS by 3c, Beats on Revenue; Offers FY26 EPS Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.64 +0.66%
EPS Growth %: -12.6%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: -12.6%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $0.75, $0.03 better than the analyst estimate of $0.72. Revenue for the quarter came in at $14.5 billion versus the consensus estimate of $13.84 billion.
GUIDANCE:
Pfizer sees FY2026 EPS of $2.80-$3.00, versus the consensus of $2.96.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nucor projects Q3 2026 earnings above prior year, below estimates
- CoTec Holdings closes $12M convertible debenture private placement
- Barclays Starts Hill & Smith Holdings Plc. (HILS:LN) at Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
